BrainsWay Past Earnings Performance
Past criteria checks 3/6
BrainsWay has been growing earnings at an average annual rate of 14.8%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 10.1% per year. BrainsWay's return on equity is 3.4%, and it has net margins of 3.9%.
Key information
14.8%
Earnings growth rate
23.9%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.1% |
| Return on equity | 3.4% |
| Net Margin | 3.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
BrainsWay: Cash Flow Doubts Weigh On The Stock
Nov 13BrainsWay: Operating Leverage Driving Upside
Aug 13BrainsWay: An Interesting Niche Concern
Jul 22BrainsWay: Profitable, Growing, And Cheap
Mar 07BrainsWay Q4 Earnings Preview
Feb 27BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS
Sep 14BrainsWay adds 20% on FDA nod for depression therapy
Aug 29Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M
Aug 10BrainsWay's Shares Look Attractive
Jul 12BrainsWay's Competitive Advantage Is Growing
Jan 21BrainsWay: Still Undervalued (Still)
Jun 02BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment
Apr 26Brainsway: Still Undervalued
Dec 24Brainsway +4% on Q3 beat, bottom-line up 66%
Nov 18Revenue & Expenses Breakdown
How BrainsWay makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 39 | 2 | 21 | 7 |
| 30 Jun 24 | 36 | 1 | 20 | 6 |
| 31 Mar 24 | 34 | -2 | 20 | 7 |
| 31 Dec 23 | 32 | -4 | 22 | 7 |
| 30 Sep 23 | 29 | -8 | 23 | 7 |
| 30 Jun 23 | 26 | -13 | 25 | 8 |
| 31 Mar 23 | 26 | -14 | 26 | 8 |
| 31 Dec 22 | 27 | -13 | 25 | 8 |
| 30 Sep 22 | 30 | -11 | 25 | 8 |
| 30 Jun 22 | 33 | -8 | 24 | 7 |
| 31 Mar 22 | 32 | -7 | 23 | 7 |
| 31 Dec 21 | 30 | -6 | 22 | 6 |
| 30 Sep 21 | 28 | -6 | 20 | 6 |
| 30 Jun 21 | 26 | -5 | 18 | 6 |
| 31 Mar 21 | 24 | -5 | 17 | 5 |
| 31 Dec 20 | 22 | -5 | 16 | 6 |
| 30 Sep 20 | 21 | -7 | 17 | 6 |
| 30 Jun 20 | 21 | -9 | 18 | 7 |
| 31 Mar 20 | 22 | -12 | 20 | 8 |
| 31 Dec 19 | 23 | -10 | 19 | 8 |
| 30 Sep 19 | 22 | -10 | 17 | 8 |
| 30 Jun 19 | 20 | -9 | 15 | 7 |
| 31 Mar 19 | 18 | -7 | 13 | 6 |
| 31 Dec 18 | 16 | -6 | 12 | 6 |
| 30 Sep 18 | 15 | -7 | 11 | 6 |
| 30 Jun 18 | 14 | -7 | 11 | 6 |
| 31 Mar 18 | 13 | -6 | 10 | 6 |
| 31 Dec 17 | 11 | -7 | 10 | 5 |
| 30 Sep 17 | 10 | -6 | 9 | 5 |
| 30 Jun 17 | 11 | -5 | 9 | 5 |
| 31 Mar 17 | 11 | -3 | 7 | 4 |
| 31 Dec 16 | 12 | -2 | 7 | 4 |
| 30 Sep 16 | 11 | -3 | 7 | 4 |
| 30 Jun 16 | 9 | -2 | 6 | 4 |
| 31 Mar 16 | 8 | -4 | 7 | 4 |
| 31 Dec 15 | 7 | -4 | 6 | 4 |
| 30 Sep 15 | 6 | -5 | 5 | 5 |
| 30 Jun 15 | 5 | -5 | 5 | 6 |
| 31 Mar 15 | 4 | -5 | 4 | 6 |
| 31 Dec 14 | 3 | -7 | 4 | 6 |
| 30 Sep 14 | 3 | -5 | 3 | 5 |
| 30 Jun 14 | 2 | -5 | 3 | 4 |
| 31 Mar 14 | 2 | -5 | 2 | 4 |
| 31 Dec 13 | 1 | -7 | 2 | 4 |
Quality Earnings: BWAY has high quality earnings.
Growing Profit Margin: BWAY became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BWAY has become profitable over the past 5 years, growing earnings by 14.8% per year.
Accelerating Growth: BWAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: BWAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: BWAY's Return on Equity (3.4%) is considered low.